All In Biotech

Drug Trial Radar · NCT06189209

Efficacy and Safety of Tenalisib in Patients With Metastatic Triple Negative Breast Cancer (TNBC)

A Phase II, Multi-center, Single-arm, Open-label Study to Assess the Efficacy and Safety of Tenalisib, a PI3K δ/γ, and SIK3 Inhibitor, in Patients With Metastatic Triple Negative Breast Cancer (TNBC)

Last checked: Nov 19, 2026Latest source record: Dec 2, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

40

Planned (sponsor's estimate)

Start

Mar 4, 2024

Primary completion

Dec 31, 2026

Study completion Mar 31, 2027

Sponsor

Lead sponsor
Rhizen Pharmaceuticals SAIndustry
Sponsor type
Industry
Collaborators
Incozen Therapeutics Pvt Ltd
First posted
Jan 3, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase II, open-label, single-arm, study, designed to evaluate the efficacy and safety of tenalisib in patients with metastatic TNBC, who have received at least one but not more than 3 prior therapies in a metastatic setting.

Conditions

  • Triple Negative Breast Cancer (TNBC)

Interventions

  • TenalisibDrug

    Tenalisib will be administered 800mg/ 400mg BID, orally

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Clinical Benefit Rate (CBR)Time frame: 1 year
  2. Duration of Clinical Benefit (DoCB)Time frame: 1 year
  3. Overall Response Rate (ORR)Time frame: 1 year
  4. Progression Free Survival (PFS)Time frame: 1 year

Locations

9 sites in 1 country. Site status is shown where the registry gives one.

  • HCG City Cancer Center

    Vijayawada, Andhra Pradesh, India · Recruiting

  • Narayana Hrudayala Majumdar Shaw Hospital

    Bangalore, Karnataka, India · Recruiting

  • Tata Memorial Centre

    Mumbai, Maharashtra, India · Recruiting

  • Mumbai Oncocare Centre

    Mumbai, Maharashtra, India · Recruiting

  • Sahyadri Super Speciality Hospital

    Pune, Maharashtra, India · Recruiting

  • Nobel Hospital

    Pune, Maharashtra, India · Recruiting

  • Meenakshi Mission Hospital & Research Center

    Madurai, Tamil Nadu, India · Not yet recruiting

  • Nizams Institute of Medical Science

    Hyderabad, Telangana, India · Not yet recruiting

  • Health Point Hospital

    Kolkata, West Bengal, India · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.